An ignored cause of red urine in children: rhabdomyolysis due to carnitine palmitoyltransferase II (CPT-II) deficiency

被引:3
|
作者
Melek, Engin [1 ]
Bulut, Fatma Derya [2 ]
Atmis, Bahriye [2 ]
Yilmaz, Berna Seker [2 ]
Bayazit, Aysun Karabay [2 ]
Mungan, Neslihan Onenli [2 ]
机构
[1] Cukurova Univ, Fac Med, Dept Pediat Nephrol, TR-013330 Adana, Turkey
[2] Cukurova Univ, Fac Med, Dept Pediat Metab, Adana, Turkey
来源
关键词
carnitine palmitoyltransferase II deficiency; dark urine; hematuria; myalgia; red urine; rhabdomyolysis; PATIENT; MUTATIONS; FEATURES;
D O I
10.1515/jpem-2016-0324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carnitine palmitoyltransferase II (CPT-II) deficiency is an autosomal recessively inherited disorder involving the beta-oxidation of long-chain fatty acids, which leads to rhabdomyolysis and subsequent acute renal failure. The clinical phenotype varies from a severe infantile form to a milder muscle form. Here, we report a 9-year-old boy referred to our hospital for the investigation of hematuria with a 2-day history of dark urine and malaise. As no erythrocytes in the microscopic examination of the urine and hemoglobinuria were present, myoglobinuria due to rhabdomyolysis was the most probable cause of dark urine. After excluding the other causes of rhabdomyolysis, with the help of metabolic investigations, the patient was suspected to have CPT-II deficiency, the most common cause of metabolic rhabdomyolysis. Our aim in presenting this case is to emphasize considering rhabdomyolysis in the differential diagnosis of dark urine in order to prevent recurrent rhabdomyolysis and renal injury.
引用
收藏
页码:237 / 239
页数:3
相关论文
共 50 条
  • [41] Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?
    Mador-House, Rachel
    Liu, Zaiping
    Dyack, Sarah
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2021, 7 (03)
  • [42] Statin use in carnitine palmitoyltransferase II deficiency
    Saeed, Anum
    Hadley, Trevor D.
    Jia, Xiaoming
    Ballantyne, Christie M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (04) : 550 - 553
  • [43] Myopathy in the course of carnitine palmitoyltransferase II deficiency
    Durka-Kesy, Marta
    Stepien, Adam
    Tomczykiewicz, Kazimierz
    Fidzianska, Anna
    Niebroj-Dobosz, Irena
    Pastuszak, Zanna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2012, 46 (06) : 600 - 602
  • [44] Antenatal presentation of carnitine palmitoyltransferase II deficiency
    Elpeleg, ON
    Hammerman, C
    Saada, A
    Shaag, A
    Golzand, E
    Hochner-Celnikier, D
    Berger, I
    Nadjari, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 102 (02): : 183 - 187
  • [45] Muscular carnitine palmitoyltransferase II deficiency in infancy
    Hurvitz, H
    Klar, A
    Korn-Lubetzki, I
    Wanders, RJA
    Elpeleg, ON
    PEDIATRIC NEUROLOGY, 2000, 22 (02) : 148 - 150
  • [46] PROFOUND CARNITINE PALMITOYLTRANSFERASE-II DEFICIENCY
    HUG, G
    BOVE, KE
    SOUKUP, S
    JOURNAL OF PEDIATRICS, 1994, 124 (01): : 159 - 160
  • [47] GENETIC ANALYSIS OF CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY
    Yasuno, Tetsuhiko
    Kaneoka, Hidetoshi
    Moriguchi, Ayaka
    Ishimura, Atsunori
    Miyahara, Yoshito
    Abe, Yasuhiro
    Saito, Takao
    NEPHROLOGY, 2005, 10 : A9 - A10
  • [48] ROLE OF CARNITINE PALMITOYLTRANSFERASE II IN DRUG-INDUCED RHABDOMYOLYSIS
    Bai, P. J.
    Abernethy, D. R.
    Guo, L.
    Liu, Z.
    Tong, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S13 - S13
  • [49] PHENOTYPE-GENOTYPE CORRELATION IN CARNITINE PALMITOYLTRANSFERASE (CPT) II DEFICIENCY: IMPLICATIONS FOR NEWBORN SCREENING
    Vladutiu, G. D.
    Isackson, P. J.
    Olson, K. R.
    Matern, D.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 54 - 55
  • [50] Recurrent post-infectious rhabdomyolysis in muscle CPT-II deficiency caused by a novel missense mutation
    van den Ameele, Jelle
    Van Landegem, William
    Wuyts, Wim
    De Bleecker, Jan
    ACTA NEUROLOGICA BELGICA, 2008, 108 (04) : 155 - 160